drugset / Trial / NCT00174798

MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

NCT00174798

Phase 2 Completed 118 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the safety and efficacy of SSR240600C versus placebo on clinical and cystometric parameters in patients with OAB and UUI.

Timeline

Start
2005-05
Primary completion
2006-05
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject BURAPITANT Small molecule 500 mg
Comparator Tolterodine Small molecule 4 mg

Indications